link to homepage

Institute of Neuroscience and Medicine

Navigation and service

Developing technologies…

To establish new therapies we implement our scientific knowledge into innovative medical devices and procedures for invasive and noninvasive neurostimulation. For a successful industrial implementation those new technologies need to be protected by letters patents.

Now we have 30 international patent families declared. Several patents have already been issued, e.g. the basic CR®- patent (Europe and USA). Also we have a close cooperation with the company Brook Henderson Group, Reading, UK. Together with our cooperation partners – based on our acoustic CR®-technology – the T30CR® System for acoustic neuromodulation (i.e. the acoustic CR®-stimulation) for the treatment of tinnitus was developed.